← Back
$RAPP All transactions

Rapport Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$809K

Shares

20,225

Price

$40

Filed

Apr 21

Insider

Name

Yeleswaram Krishnaswamy

Title

Chief Development Officer

CIK

0002022156

Roles

Officer

Transaction Details

Transaction Date

2026-04-17

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

246,426

Footnotes

These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025. | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.90 to $40.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Filing Info

Accession No.

0001193125-26-167091

Form Type

4

Issuer CIK

0002012593

Yeleswaram Krishnaswamy's History

Date Ticker Type Value
2026-04-17 RAPP $809K
2026-04-14 RAPP $358K
2026-04-13 RAPP $321K
2026-04-10 RAPP $17K
2026-04-08 RAPP $13K
2026-03-25 RAPP $303K

Other Insiders at RAPP (90d)

Insider Bought Sold Last
Third Rock Ventures V, L.P. $17.2M 2026-04-17
Gault Cheryl
Chief Operating Officer
$282K 2026-03-30
Yeleswaram Krishnaswamy
Chief Development Officer
$1.0M 2026-04-14